Review
Full Access
Cell-Mediated Immunity in Virus Infections (Nobel Lecture)†
Prof. Peter C. Doherty,
Corresponding Author
Prof. Peter C. Doherty
Department of Immunology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38104 (USA), Fax: Int. code +(901)495-3107
Department of Immunology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38104 (USA), Fax: Int. code +(901)495-3107Search for more papers by this authorProf. Peter C. Doherty,
Corresponding Author
Prof. Peter C. Doherty
Department of Immunology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38104 (USA), Fax: Int. code +(901)495-3107
Department of Immunology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38104 (USA), Fax: Int. code +(901)495-3107Search for more papers by this author†
Copyright© The Nobel foundation 1997. We thank the Nobel Foundation, Stockholm, for permission to print this lecture.
Abstract
“Being isolated in those pre-fax and pre-e-mail days in Australia was a great advantage, as it allowed time to discuss and to think things through. We had outspoken and informed local critics, the freedom and resources to pursue our own ideas, and were given full credit for our efforts. Those of us who have senior roles in science need to do everything possible to ensure that comparable opportunities and environments remain available to young scientists.” With this provocative exhortation P.C. Doherty ended his Nobel Lecture.
References
- 1 “The neutralization for viruses”: S. Fazekas de St. Groth, Adv. Virus Res. 1962, 9, 1.
- 2 “Three-dimensional structure of a complex of antibody with influenza virus neuraminidase”: P. M. Colman, W. G. Laver, J. V. Varghese, A. T. Baker, P. A. Tulloch, G. M. Air, R. G. Webster, Nature 1987 326, 358.
- 3 “T-cell-mediated immunopathology in viral infections”: P. C. Doherty, R. M. Zinkernagel, Transplant. Rev. 1974, 19, 89.
- 4 “Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system”: R. M. Zinkernagel, P. C. Doherty, Nature, 1974, 248 701.
- 5 “Immunological surveillance against altered self components by sensitised T lymphocytic n lymphocytes choriomeningitis”: R. M. Zinkernagel, P. C. Doherty, Nature 1974, 251, 547.
- 6 “A biological role for the major histocompatibility antigens”: P. C. Doherty, R. M. Zinkernagel, Lancet 1975, 1, 1406.
- 7 “The clinical features and pathogenesis of mouse-pox (infectious ectromclia of mice)” F. Fenner, J. Pathol. Bacteriol. 1948, 4 529.
- 8 “A modification of Jerne's theory of antibody production using the concept of clonal selection”: F. M. Burnet, Aust. J. Sci. 1957, 20: 67.
- 9 “Pathogenesis of rashes in virus diseases”: C. A. Mims, Bacteriol. Rev. 1966. 30, 739.
- 10 “Cellular immunity”: G. B. Mackaness, R. V. Blanden, Prog. Allergy. 1967, 11, 89.
- 11 “Mechanisms of recovery from a generalized viral infection: mousepox, 1 The effects of anti-thymocyte serum”: R. V. Blanden, J. Exp. Med. 1970, 132, 1035.
- 12 “Mechanisms of recovery from a generalized viral infection: mousepox. II Passive transfer of recovery mechanisms with immune lymphoid cells”: R. V. Blanden, J. Exp. Med. 1971, 133, 1074.
- 13 “Mechanisms of recovery from a generalized viral infection: mousepox. 3, Regression of infectious foci”: R. V. Blanden, J. Exp. Med. 1971, 133, 1090.
- 14 “Quantitative studies of the inflammatory process in fatal viral meningoencephalitis”: P. C. Doherty Am. J. Pathol. 1973, 73, 607.
- 15 “Higher frequency of a protein band in the cerebrospinal fluid from scrapie mice”: P. A. Merz, G. S. Merz, R. I. Carp. Res. Vet. Sci. 1973, 14, 392.
- 16
“Protective effect of neonatal thymectomy on mouse LCM infection”:
W. P. Rowe,
P. H. Black,
R. H. Levey,
Proc. Soc, Exp. Biol. Med.
1963,
14, 248.
10.3181/00379727-114-28643 Google Scholar
- 17 “Protection against the lethal effects of lymphocytic choriomeningitis virus in mice by neonatal thymectomy”: J. Hotchin, E. Sikora, Nature, 1964, 202, 214.
- 18 “Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers”: D. H. Gilden, G. A. Cole, N. Nathanson, J. Exp. Med. 1972, 135, 874.
- 19 “Cell-mediated cytotoxicity, allograft rejection, and tumor Immunity”: J. C. Cerottini, K. T. Brunner, Adv. Immunol. 1974, 18, 67.
- 20 “Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells”: M. B. A. Oldstone, F. J. Dixon, Virology 1970, 42, 805.
- 21 “Studies on cell-mediated immunity of lymphocytic choriomeningtis virus in mice”: O. Marker, M. Volkert, J. Exp. Med. 1973, 137, 1511.
- 22 “Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis”: R. M. Zinkernagel, P. C. Doherty. J. Exp. Med. 1973, 138, 1266.
- 23 “Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymhocyte interactions”: D. H. Katz, T. Hamaoka, M. E. Dorf, B. Benacerraf, Proc. Natl. Acad. Sci. USA 1973, 70, 2624.
- 24 “Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes”: A. S. Rosenthal, E. M. Shevach, J. Exp. Med. 1973, 138, 1194.
- 25 “The hostocompatibility-linked immune response genes”: B. Benacerraf, D. H. Katz, Adv. Cancer Res. 1975, 21, 121.
- 26 “ Biology of the Mouse Histocompatibility-2 Complex”: Springer, Berlin, 1975.
- 27 “Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection”: M. B. Oldstone, F. J. Dixon, G. F. Mitchell, H. O. McDevitt, J. Exp. Med. 1973, 137, 1201.
- 28 “Peritoneal macrophages as target cells for measuring virus-specific T cell mediated cytotoxicity in vitro”: R. M. Zinkernagel, P. C. Doherty, J. Immunol. Methods 1975, 8, 263.
- 29 “H-2 compatibility is required for T-Cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus”: P. C. Doherty, R. M. Zinkernagel, J. Exp. Med. 1975, 141, 502.
- 30 “Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype”: P. C. Doherty, W. E. Biddison, J. R. Bennink, B. B. Knowles, L. Exp. Med. 1978, 148, 534.
- 31 “Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness”: R. M. Zinkernagel. A. Althage, S. Cooper, G. Kreeb, P. A. Klein, B. Sefton, L. Flaherty, J. Stimpfling, D. Shreffler, J. Klein. J. Exp. Med. 1978, 148, 592.
- 32 “Cell-mediated cytotoxicity against ectromelia virus-infected target cells. III Role of the H-2 gene complex”: I. D. Gardner, N. A. Bowern, R. V. Blanden, Eur, J. Immunol. 1975, 5 122.
- 33 “Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex”: R. V. Blanden, P. C. Doherty, M. B. Dunlop, I. D. Gardner, R. M. Zinkernagel, C. S. David, Nature 1975, 254, 269.
- 34 “Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity”: P. C. Doherty, R. V. Blanden, R. M. Zinkernagel, Transplant. Rev. 1976, 29, 89.
- 35
“Cellular immune recognition and the biological role of Major transplantation antigens (Nobel Lecture)”:
R. M. Zinkernagel,
Angew. Chem.
1997,
109, 2026;
10.1002/ange.19971091805 Google Scholar“(Nobel Lecture)”: R. M. Zinkernagel, Angew. Chem. 1997, 36, 1938.
- 36 “The major histocompatibility complex determines susceptibility to cytotoxic T Cells directed against minor histocompatibility antigens”: M. J. Bevan, J. Exp. Med. 1975, 142 1349.
- 37 “In vitro cell-mediated immune response to the male specific (HY) antigen in mice”: R. D. Gordon, E. Simpson, L. E. Samelson, J. Exp. Med. 1975, 142, 1108.
- 38 “England immunological surveillance in mice heterozygous at the H-2 gene complex”: P. C. Doherty, R. M. Zinkernagel, Nature 1975, 256, 50.
- 39 “Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function”: P. C. Doherty, B. B. Knowles, P. J. Wettstein, adv. Cancer Res. 1984, 42, 1.
- 40 “Immunological surveillance in neoplasia”: F. M. Burnet, Transplant. Rev. 1971, 7, 3.
- 41 “The response to H-2 different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment”: J. R. Bennink, P. C. Doherty, Cell. Immunol. 1981, 61, 220.
- 42 “ Historical developments in understanding the function of class I MHC genes”: P. C. Doherty in H-2 Antigens, Genes Molecules and Functions (Ed.: C. S. David), NATO ASI series, Plenum Press, New York, 1987, p. 341.
- 43 “The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides”: A. R. Townsed. J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, A. J. McMichael, Cell, 1986, 44, 959.
- 44 “The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens”: P. J. Bjorkman, M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, D. C. Wiley, Nature 1987, 329, 512.
- 45 “T cell receptor gene diversity and selection”: M. M. Davis, Annu. Rev. Biochem. 1990, 59, 475.
- 46 “An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex”: K. C. Garcia, M. Degano, R. L. Stanfield. A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, I. A. Wilson Science 1996, 274, 209.
- 47 “Structure of the complex between human T cell receptor, viral peptide and HLA-A2”: D. N. Garboczi, P. Ghosh, Q. R. Fan, W. E. Biddison, D. C. Wiley, Nature 1996, 384, 134.
- 48 “hsp65 mRNA+ macrophages and γδ T cells in influenza virus-infected mice depleted of the CD4+ and CD8+ lymphocyte subsets”: W. Allan, S. R. Carding, M. Eichelberger, P. C. Doherty, Microb. Pathog. 1993, 14, 75.
- 49 “Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis virus”: R. V. Blanden, C. A. Mims. Aust.: J. Exp. Biol. Med. Sci. 1973, 51, 393.
- 50 “Phenotypic and functional analysis of the cellular response in regional lymphoid tissue during an acute virus infection”: F. Lynch, P. C. Doherty, R. Ceredig, J. Immunol. 1989, 142, 3592.
- 51 “Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex”: P. C. Doherty, R. M. Zinkernagel, J. Immunol. 1975, 114, 30.
- 52 “Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions”: P. C. Doherty, M. B. Dunlop, C. R. Parish, R. M. Zinkernagel, J. Immunol. 1976, 117, 187.
- 53 “Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver”: L. G. Guidotti, P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. A. Oldstone, F. V. Chisari, Proc. Natl. Acad. Sci. USA 1996, 93, 4589.
- 54 “Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection”: P. C. Doherty, J. E. Allan, Eur. J. Immunol. 1986, 16, 1237, 1646.
- 55 “Immunogenetic analysis of cellular interactions governing the recruitment of T lymphocytes and monocytes in lymphocytic choriomeningitis virus-induced immunopathology”: P. C. Doherty, R. Ceredig, J. E. Allan, Clin, Immunol. Immunopathol. 1988, 47, 19.
- 56 “Dissection of an inflammatory process induced by CD8 + T cells”: P. C. Doherty, J. E. Allan, F. Lynch, R. Ceredig, Immunol. Today 1990, 11, 55.
- 57 “Cytotoxicity mediated by T cells and natural killer cells in greatly impaired in perforin-deficient mice”: D. Kagi, B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, H. Hengartner, Nature 1994, 369, 31.
- 58 “Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression”: W. P. Fung-Leung, T. M. Kundig, R. M. Zinkernagel, T. W. Mak, J. Exp. Med. 1971, 174, 1425.
- 59 “Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins”: P. C. Doherty, S. Hou, P. J. Southern, J. Neuroimmunol. 1993, 46, 11.
- 60 “Antiviral immune response of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene”: F. Lehmann-Grube, J. Lohler, O. Utermohlen, C. Gegin, J. Virol. 1993, 67, 332.
- 61 “Beta 2-microglobulin deficient mice lack CD4–8+ cytolytic T cells”: M. Zijlstra, M. Bix, N. E. Simister, J. M. Loring, D. H. Raulet, R. Jaenisch, Nature, 1990, 344, 742.
- 62 “Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes”: P. C. Doherty, R. M. Zinkernagel, Immunology 1976, 31, 27.
- 63 “Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus”: U. Koszinowski, H. E. Ertl, Nature 1976, 255, 552.
- 64 “Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells”: S. Hou, P. C. Doherty, M. Zijlstra, R. Zaenisch, J. M. Katz, J. Immunol. 1992, 149, 1319.
- 65 “Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins”: S. Hou, X. Y. Mo, L. Hyland, P. C. Doherty, J. Virol. 1995, 69, 1429.
- 66 “Evolution and ecology of influenza A viruses”: R. G. Webster, W. J. Bean, O. T. Gorman, T. M. Chambers, Y. Kawaoka, Microbiol. Rev.1992, 56, 152.
- 67 “Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses”: R. B. Effros, P. C. Doherty, W. Gerhard, J. Bennink, J. Exp. Med. 1977, 145, 557.
- 68 “Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza virus”: P. C. Doherty, R. B. Effros, J. Bennink, Proc. Natl. Acad. Sci. USA 1977, 74, 1209.
- 69 “Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses”: H. J. Zweerink, S. A. Courtneidge, J. J. Skehel, M. J. Crumpton, B. A. Askonas, Nature 1977, 267, 354.
- 70
“MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness”:
R. M. Zinkernagel,
P. C. Doherty,
Adv. Immunol.
1970,
27, 51.
10.1016/S0065-2776(08)60262-X Google Scholar
- 71 “Characteristics of secondary cytotoxic T-cell responses in mice infected with influenza A viruses”: R. B. Effros, J. Bennink, P. C. Doherty, Cell, Immunol. 1978, 36, 345.
- 72 “The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants”: M. E. Andrew, B. E. Coupar, D. B. Boyle, G. L. Ada. Scand. J. Immunol. 1987, 25, 21.
- 73 “Recombinant vaccinia viruses and the development of immunization strategies using influenza virus”: P. C. Doherty, W. Allan, D. B. Boyle, B. E. Coupar, M. E. Andrew, J. Infect. Dis. 1989, 159, 1119.
- 74 “Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge”: C. M. Lawson, J. R. Bennink, N. P. Restifo, J. W. Yewdell, B. R. Murphy, J. Virol 1994, 68, 3505.
- 75 “Experiments and speculation on antiviral specificity of T and B cells”: R. M. Zinkernagel, K. L. Rosenthal, Immunol. Rev. 1981, 58, 131.
- 76 “The control of specificity of cytotoxic T lymphocytes by the major histocompatibility complex (AG-B) in rats and identification of a new alloantigen system showing no AG-B restriction”: A. Marshak, P. C. Doherty, D. B. Wilson, J. Exp. Med. 1977, 146, 1773.
- 77 “HLA restriction of cell-mediated lysis of influenza virus-infected human cells”: A. J. McMichael, A. Tig, H. J. Zweerink, B. A. Askonas, Nature 1977, 270, 524.
- 78 “Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells”: A. R. Townsend, A. J. McMichael, N. P. Carter, J. A. Huddleston, G. G. Brownlee, Cell 1984, 39, 13.
- 79 “Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function”: J. R. Bennink, J. W. Yewdell, Curr. Top. Microbiol. Immunol. 1990, 163, 153.
- 80 “In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific”: A. E. Lukacher, V. L. Braciale, T. J. Braciale, J. Exp. Med. 1984, 160, 814.
- 81 “Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial viruses”: P. J. Openshaw, Clin. Exp. Immunol. 1989, 75, 324.
- 82 “Roles of alpha beta and gamma delta T cell subsets in viral immunity”: P. C. Doherty, W. Allan, M. Eichelberger, S. R. Carding, Annu, Rev. Immunol. 1992, 10, 123.
- 83 “ Immune response to virus”: P. C. Doherty in Clinical Immunology, Principles and Practice, (Eds.: R. R. Rich, T. A. Fleischer, B. D. Schwartz, W. T. Shearer, W. Strober), Mosby, St. Louis, 1996, p. 535.
- 84 “Influenza virus RNA in the lung an lymphoid tissue of immunologically intact and CD4-depleted mice”: M. C. Eichelberger, M. Wang, W. Allan, R. G. Webster, P. C. Doherty, J. Gen. Virol. 1991, 72, 1695.
- 85 “Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory”: P. C. Doherty, D. J. Topham, R. A. Tripp, Immunol. Rev. 1996, 150, 23.
- 86 “Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus-infected epithelium”: S. Hou, P. C. Doherty, Eur. J. Immunol. 1995, 25, 111.
- 87 “Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells”: M. Eichelberger, W. Allan, M. Zijlstra, R. Jaenisch, P. C. Doherty, J. Exp. Med. 1991, 174, 875.
- 88 “Transgenic mice lacking class I M major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge”: B. S. Bender, T. Croghan, L. Zhang, P. A. Small, Jr. J. Exp. Med. 1992, 175, 1143.
- 89 “β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase”: S. L. Epstein, J. A. Misplon, C. M. Lawson, E. K. Subbarao, M. Connors, B. R. Murphy, J. Immunol. 1993, 150, 5484.
- 90 “Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II-/-respiratory epithelium”: D. J. Topham, R. A. Tripp, S. R. Sarawar, M. Y. Sangster, P. C. Doherty, J. Virol. 1996, 70, 1288.
- 91 “Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia is SCID mice”: G. Palladino, K. Mozdzanowska, G. Wasko, W. Gerhard, J. Virol. 1995, 69, 2075.
- 92 “Louping ill encephalomyelitis in the sheep. IV. Nature of the perivascular inflammatory reaction”: P. C. Doherty, H. W. Reid, W. Smith, J. Comp. pathol. 1971, 81, 545.
- 93 “Louping-ill encephalomyelitis in the sheep”; P. C. Doherty, H. W. Reid, J. Comp. Pathol. 1971, 81, 531.
- 94 “Louping-ill encephalomyelitis in the sheep. 3, Immunoglobulins in cerebrospinal fluid”: H. W. Reid, P. C. Doherty, A. M. Dawson, J. Comp. Pathol. 1971, 81, 537.
- 95 “Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice”: W. R. Tyor, D. E. Griffin, J. Neuroimmunol. 1993, 48, 37.
- 96 “Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis”: R. Ceredig, J. E. Allan Z. Tabi, F. Lynch, P. C. Doherty, J. Exp. Med. 1987, 165, 1539.
- 97 “Contributions of host donor T Cells to the inflammatory process in murine lymphocytic choriomeningitis”: P. C. Doherty, J. E. Allan, R. Ceredig, Cell. Immunol. 1988, 116, 475.
- 98 “Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells”: W. Allan, Z. Tabi, A. Cleary, P. C. Doherty, J. Immunol. 1990, 144, 1380.
- 99 “Recruitment and proliferation of CD8+ T cells in respiratory virus infections”: R. A. Tripp, S. Hou, A. McMickle, J. Houston, P. C. Doherty, J. Immunol. 1995, 154, 6013.
- 100 “Virus-specific CD8+ T cell memory determined by clonal burst size”: S. Hou, L. Hyland, K. W. Ryan, A. Porter, P. C. Doherty, Nature 1994, 369, 652.
- 101 “Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-21Ab gene”: R. A. Trip, S. R. Sarawar, P. C. Doherty, J. Immunol. 1995, 155, 2955.
- 102 “Environmental modulation of the autonomy of cytotoxic T. lymphocytes”: H. Bodmer, G. Obert, S. Chan, C. Benoist, D. Mathis, Eur. J. Immunol. 1993, 23, 1649.
- 103 “Reciprocal stimulation of negatively selected high-responder and low-responder T cells in virusinfected recipients”: J. R. Bennink, P. C. Doherty, Proc. Nat. Acad. Sci. USA 1979, 76, 3482.
- 104 “How selective is the transporter associated with antigen processing?”: M. J. Androwlewicz. P. Creswell, Immunity 1996, 5, 1.
- 105 “Limiting dilution analysis of the specificit of influeza-immune cytotoxic T cells”: J. A. Owen, M. Allouche, P. C. Doherty, Cell, Immunol. 1982, 67, 49.
- 106 “Limit-dilution analysis of weak influenza-immune T cell responses associated with H-2Kb and H-2Db”: M. Allouche, J. A. Owen, P. C. Doherty, J. Immunol. 1982, 129, 689.
- 107 “Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity”: S. Webb, C. Morris, J. Sprent, Cell 1990, 63, 1249.
- 108 “Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen”: J. E. McCormack, J. E. Callahan, J. Kappler, P. C. Marack, J. Immunol. 1993, 150, 3785.
- 109 “Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells”: R. A. Tripp, S. Hou, P. C. Doherty, J. Immunol. 1995, 154, 5870.
- 111 “Independent populations of primed F1 guinea pig T lymphocytes respond to antigen-pulsed parental peritoneal exudate cells”: W. W. Paul, E. M. Shevach, S. Pickeral, D. W. Thomas, A. S. Rosenthal, J. Exp. Med. 1977, 145, 618.
- 112 “Laser light suicide of proliferating virus-specific CD8+ T cells in an in vivo response”: R. A. Tripp, J. M. Lahti, P. C. Doherty, J. Immunol. 1995, 155, 3719.
- 113 “Turnover of naive-and memory-phenotype T cells”: D. F. Tough, J. Sprent, J. Exp. Med. 1994, 179, 1127.
- 114 “Lymphocyte lifespans: homeostasis, selection and competition”: A. A. Freitas, B. B. Rocha, Immunol. Today 1993, 14, 25.
- 115 “Tolerance, danger, and the extended family”: P. Matzinger, Annu. Rev. Immunol. 1994, 12, 991.
- 116 “HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span and viral generation time”: A. S. Perelson, A. U. Neuman, M. Markowit, J. M. Leonard, D. D. Ho, Science 1996, 271, 1582.
- 117 Complexity: the emerging science at the edge of chaos. M. W. Waldrop, Simon and Schuster, New York, 1992.
- 118 “Immunity to viruses”: P. C. Doherty, The Immunologist 1995, 3, 231.
- 119 “Quantitative analysis of influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig”: D. J. Topham, R. A. Tripp. A.-M. Hamilton-Easton, S. R. Sarawar, P. C. Doherty, J. Immunal 1996, 157, 2947.
- 120 “Progressive loss of CD8+ T cell-mediated control of a γ-herpesvirus in the absence of CD4+ T cells”: R. D. Cardin, J. W. Brooks, S. R. Sarawar, P. C. Doherty, Exp. Med. 1996, 184, 863.
- 121 “Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype”G: S. Hou, P. C. Doherty, J. Immunol. 1993, 150, 5494.
